Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 12/20 | 0.42 |
| ▸ | DRD1 | P21728 | 5/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | GPR183 | P32249 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL51116 | 0.82 | DRD2 (0.59) | DRD2DRD1TSHRMEN1KMT2A | |
| SCHEMBL1559611 | 0.81 | DRD2 (0.46) | DRD2DRD1 | |
| SCHEMBL1559613 | 0.81 | DRD2 (0.46) | DRD2DRD1 | |
| SCHEMBL1362677 | 0.81 | DRD2 (0.46) | DRD2DRD1 | |
| SCHEMBL4551311 | 0.79 | DRD2 (0.62) | DRD2DRD1UCHL1 | |
| SCHEMBL4551313 | 0.79 | DRD2 (0.62) | DRD2DRD1UCHL1 | |
| SCHEMBL1360527 | 0.79 | DRD2 (0.62) | DRD2DRD1UCHL1 | |
| SCHEMBL1360447 | 0.79 | DRD2 (0.41) | DRD2DRD1TSHROPRK1ALDH1A1 | |
| SCHEMBL4552915 | 0.79 | DRD2 (0.41) | DRD2DRD1TSHROPRK1ALDH1A1 | |
| SCHEMBL4552914 | 0.79 | DRD2 (0.41) | DRD2DRD1TSHROPRK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067410-B2 | Phenolic and catecholic amines and prodrugs thereof | H. LUNDBECK A/S (DK) | 2011-11-29 | — | — | US | disclosed |
| US-8067410-B2 | Phenolic and catecholic amines and prodrugs thereof | H. LUNDBECK A/S (DK) | 2011-11-29 | — | — | US | disclosed |
| US-8067410-B2 | Phenolic and catecholic amines and prodrugs thereof | H. LUNDBECK A/S (DK) | 2011-11-29 | — | — | US | disclosed |
| US-20090325946-A1 | NOVEL PHENOLIC AND CATECHOLIC AMINES AND PRODRUGS THEREOF | H. LUNDBECK A/S (DK) | 2009-12-31 | — | — | US | disclosed |
| US-20090325946-A1 | NOVEL PHENOLIC AND CATECHOLIC AMINES AND PRODRUGS THEREOF | H. LUNDBECK A/S (DK) | 2009-12-31 | — | — | US | disclosed |
| WO-2009156458-A1 | NOVEL PHENOLIC AND CATECHOLIC AMINES AND PRODRUGS THEREOF | H. LUNDBECK A/S (DK) | 2009-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325946-A1 | NOVEL PHENOLIC AND CATECHOLIC AMINES AND PRODRUGS THEREOF | COMT, PNMT, TYR | DRD2 210/4885DRD1 515/4885CYP2D6 193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.